138 related articles for article (PubMed ID: 11735695)
1. Delayed cutaneous hypersensitivity reactions to hirudin.
Smith KJ; Rosario-Collazo J; Skelton H
Arch Pathol Lab Med; 2001 Dec; 125(12):1585-7. PubMed ID: 11735695
[TBL] [Abstract][Full Text] [Related]
2. Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin.
Carr CS; Rayner A; Ponte J; Desai JB
Ann Thorac Surg; 2005 Feb; 79(2):696-8. PubMed ID: 15680867
[TBL] [Abstract][Full Text] [Related]
3. [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy].
Folwaczny EK; Stürmer KM
Chirurg; 2002 Dec; 73(12):1197-203. PubMed ID: 12491049
[TBL] [Abstract][Full Text] [Related]
4. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration.
Jappe U; Reinhold D; Bonnekoh B
Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of subcutaneous hirudins.
Deitcher SR
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S27-31. PubMed ID: 14593980
[TBL] [Abstract][Full Text] [Related]
6. [A study of 19 cases of allergy to heparins with positive skin testing].
Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
8. [R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection].
Shah AC; Genoni M; Niederhäuser U; Maloigne M; Turina M
Schweiz Med Wochenschr; 2000 Jun; 130(23):896-9. PubMed ID: 10897491
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
10. [Allergy to heparin, heparinoids, and recombinant hirudin. Diagnostic and therapeutic alternatives].
Jappe U; Gollnick H
Hautarzt; 1999 Jun; 50(6):406-11. PubMed ID: 10427508
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.
Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Anguenot T; Bernard Y; Bassand JP
Am J Hematol; 1995 Sep; 50(1):20-5. PubMed ID: 7668220
[TBL] [Abstract][Full Text] [Related]
12. Stroke risk with higher heparin, hirudin dosages halts studies.
Am J Health Syst Pharm; 1995 Jan; 52(1):8, 10. PubMed ID: 12879517
[No Abstract] [Full Text] [Related]
13. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
14. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
Antman EM
Circulation; 1996 Sep; 94(5):911-21. PubMed ID: 8790025
[TBL] [Abstract][Full Text] [Related]
15. The complex clinical picture of side effects to anticoagulation.
Trautmann A; Seitz CS
Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
[TBL] [Abstract][Full Text] [Related]
16. Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).
Close P; Bichler J; Kerry R; Ekman S; Bueller HR; Kienast J; Marbet GA; Schramm W; Verstraete M
Coron Artery Dis; 1994 Nov; 5(11):943-9. PubMed ID: 7719527
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: a critical risk/benefit analysis of patients in intensive care treated with R-hirudin.
Schenk JF; Berg G; Mörsdorf S; Stefan B; Kroll H; Krischek B; Pindur G; Schieffer H; Wenzel E
Clin Appl Thromb Hemost; 2000 Jul; 6(3):151-6. PubMed ID: 10898275
[TBL] [Abstract][Full Text] [Related]
19. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
Antman EM
Circulation; 1994 Oct; 90(4):1624-30. PubMed ID: 7923644
[TBL] [Abstract][Full Text] [Related]
20. [Atypical heparin-induced thrombocytopenia (HIT)--"heparin allergy" with thrombocytosis].
Folwaczny EK; Stürmer KM
Chirurg; 1999 May; 70(5):588-93; discussion 593-4. PubMed ID: 10412604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
